Glaxosmithkline Capital Inc Sample Contracts

INDENTURE among
Glaxosmithkline Capital Inc • September 2nd, 2003 • Pharmaceutical preparations • New York
Sample 1Sample 2Sample 3See All (1k)
AutoNDA by SimpleDocs
EXHIBIT 1.1 [FORM OF UNDERWRITING AGREEMENT] UNDERWRITING AGREEMENT
Underwriting Agreement • September 2nd, 2003 • Glaxosmithkline Capital Inc • Pharmaceutical preparations • New York
Sample 1Sample 2Sample 3See All (1k)
INDENTURE among
Glaxosmithkline Capital Inc • September 2nd, 2003 • Pharmaceutical preparations • New York
Sample 1Sample 2Sample 3See All (528)
UNDERWRITING AGREEMENT among GLAXOSMITHKLINE CAPITAL INC. as Issuer GLAXOSMITHKLINE PLC as Guarantor and as Representatives of the Underwriters Dated as of [ ], 20[ ]
Underwriting Agreement • March 28th, 2018 • Glaxosmithkline Capital Inc • Pharmaceutical preparations • New York

Note: A securities rating is not a recommendation to buy, sell or hold securities and may be subject to revision or withdrawal at any time.

Sample 1Sample 2Sample 3See All (9)
Contract
Indenture • March 21st, 2014 • Glaxosmithkline Capital Inc • Pharmaceutical preparations • New York

SECOND SUPPLEMENTAL INDENTURE dated as of March 21, 2014, among GlaxoSmithKline Capital Inc., a corporation organized under the laws of the State of Delaware (the “Company”), GlaxoSmithKline plc, a public limited company incorporated under the laws of England and Wales, as guarantor (the “Guarantor”), and Law Debenture Trust Company of New York (as successor to Citibank, N.A.), a company duly organized and existing under the laws of the State of New York (the “Trustee”).

Sample 1Sample 2
UNDERWRITING AGREEMENT among GLAXOSMITHKLINE CAPITAL INC. as Issuer GSK PLC as Guarantor and as Representatives of the Underwriters Dated as of [ ], 20[ ]
Underwriting Agreement • March 10th, 2023 • Glaxosmithkline Capital Inc • Pharmaceutical preparations • New York
Sample 1Sample 2
Contract
First Supplemental Indenture • March 21st, 2014 • Glaxosmithkline Capital Inc • Pharmaceutical preparations • New York

FIRST SUPPLEMENTAL INDENTURE dated as of March 21, 2014, among GlaxoSmithKline Capital plc, a public limited company incorporated under the laws of England and Wales (the “Company”), GlaxoSmithKline plc, a public limited company incorporated under the laws of England and Wales, as guarantor (the “Guarantor”), and Law Debenture Trust Company of New York (as successor to Citibank, N.A.), a company duly organized and existing under the laws of the State of New York (the “Trustee”).

Sample 1Sample 2
Contract
First Supplemental Indenture • March 21st, 2014 • Glaxosmithkline Capital Inc • Pharmaceutical preparations • New York

FIRST SUPPLEMENTAL INDENTURE dated as of March 21, 2014, between GlaxoSmithKline plc, a public limited company incorporated under the laws of England and Wales (the “Company”) and Law Debenture Trust Company of New York, a company duly organized and existing under the laws of the State of New York (the “Trustee”).

Sample 1Sample 2
UNDERWRITING AGREEMENT among GLAXOSMITHKLINE CAPITAL plc as Issuer GSK plc as Guarantor and as Representatives of the Underwriters Dated as of [ ], 20[ ]
Underwriting Agreement • March 25th, 2024 • Glaxosmithkline Capital Inc • Pharmaceutical preparations • New York
Sample 1Sample 2
Contract
Third Supplemental Indenture • May 15th, 2018 • Glaxosmithkline Capital Inc • Pharmaceutical preparations • New York

THIRD SUPPLEMENTAL INDENTURE dated as of May 15, 2018, among GlaxoSmithKline Capital Inc., a corporation organized under the laws of the State of Delaware (the “Company”), GlaxoSmithKline plc, a public limited company incorporated under the laws of England and Wales, as guarantor (the “Guarantor”), and Deutsche Bank Trust Company Americas, a New York banking corporation duly organized and existing under the laws of New York (the “Trustee”) (as successor to Law Debenture Trust Company of New York, (the “Former Trustee”) which was a successor to Citibank, N.A. (the “Original Trustee” )).

Sample 1
UNDERWRITING AGREEMENT between GLAXOSMITHKLINE PLC as Issuer and as Representatives of the Underwriters Dated as of [ ], 20[ ]
Underwriting Agreement • March 28th, 2018 • Glaxosmithkline Capital Inc • Pharmaceutical preparations • New York
Sample 1
UNDERWRITING AGREEMENT between GSK PLC as Issuer and as Representatives of the Underwriters Dated as of [ ], 20[ ]
Underwriting Agreement • March 10th, 2023 • Glaxosmithkline Capital Inc • Pharmaceutical preparations • New York
Sample 1
UNDERWRITING AGREEMENT between GSK plc as Issuer and as Representatives of the Underwriters Dated as of [ ], 20[ ]
Underwriting Agreement • March 25th, 2024 • Glaxosmithkline Capital Inc • Pharmaceutical preparations • New York
Sample 1
Contract
Second Supplemental Indenture • May 15th, 2018 • Glaxosmithkline Capital Inc • Pharmaceutical preparations • New York

SECOND SUPPLEMENTAL INDENTURE dated as of May 15, 2018, among GlaxoSmithKline Capital plc, a public limited company incorporated under the laws of England and Wales (the “Company”), GlaxoSmithKline plc, a public limited company incorporated under the laws of England and Wales, as guarantor (the “Guarantor”), and Deutsche Bank Trust Company Americas, a New York banking corporation duly organized and existing under the laws of New York (the “Trustee”) (as successor to Law Debenture Trust Company of New York, (the “Former Trustee”) which was a successor to Citibank, N.A. (the “Original Trustee” ).

Sample 1
Time is Money Join Law Insider Premium to draft better contracts faster.